The chicken chemotactic and anciogenic factor (9E3 gene product): Its angiogenic properties reside in the C-terminus of the molecule

Cytokine

Volumn 10, Issue 11, 1998, Pages 819-830

  Martins Green, Manuela ^a   Kelly, Thomas ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

9E3; Angiogenesis; cCAF; Chemokine; Cytokine; Wounding healing

Indexed keywords

ANGIOGENIC FACTOR; CHEMOKINE; ALPHA CHEMOKINE; AVIAN PROTEIN; CYTOKINE; EMF 1 PROTEIN, GALLUS GALLUS; EMF-1 PROTEIN, GALLUS GALLUS;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CARBOXY TERMINAL SEQUENCE; CHICKEN; CHORIOALLANTOIS; CONTROLLED STUDY; GRANULATION TISSUE; LEUKOCYTE; MICROVASCULATURE; NONHUMAN; PRIORITY JOURNAL; STRUCTURE ACTIVITY RELATION; ANIMAL; CHEMOTAXIS; CHICK EMBRYO; PHYSIOLOGY;

ANIMALIA; GALLUS GALLUS;

ANGIOGENESIS INDUCING AGENTS; ANIMALS; AVIAN PROTEINS; CHEMOKINES, CXC; CHEMOTAXIS; CHICK EMBRYO; CYTOKINES; NEOVASCULARIZATION, PHYSIOLOGIC;

EID: 0032217099     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1006/cyto.1998.0383     Document Type: Article

References (64)

1. 1. Taub DD, Oppenheim JJ (1994) Chemokines, inflammation and the immune system. Therapeutic Immunol 1:229-246.
2. 2. Baggiolini M, Dewald B, Moser B (1994) Interleukin-8 and related chemotactic cytokines - CXC and CC chemokines. Adv Immunol 55:97-179.
3. 3. Prieschl EE, Kulmburg PA, Baumruker T (1995) The nomenclature of chemokines. Internatl Archives Allergy Immunol 107:475-483.
4. 4. Wilmer JL, Burleson FG, Kayama F, Kanno J, Luster MI (1994) Cytokine induction in human epidermal keratinocytes exposed to contact irritants and its relation to chemical-induced inflammation in mouse skin. J Invest Dermatol 102:915-922.
5. 5. Strieter RM, Polverini PJ, Arenberg DA, Kundel SL (1995a) The role of CXC chemokines as regulators of angiogenesis. Shock 4:155-160.
6. 6. Nanney LB, Mueller SG, Bueno R, Peiper SC, Richmond A (1995) Distribution of melanoma growth stimulatory activity or growth-regulated gene and the interleukin-8 receptor B in human wound repair. Am J Pathol 147:1248-1260.
7. 7. Martins-Green M, Hanafusa H (1997) The 9E3/CEF4 gene and its product the chicken Chemotactic and Angiogenic Factor (cCAF): potential roles in wound healing and tumor development. Cytokines Growth Factors 8(3):219-230.
8. 8. Sugano S, Stoeckle MY, Hanafusa H (1987) Transformation by Rous sarcoma virus induces a novel gene with homology to a mitogenic platelet protein. Cell 49:321-328.
9. 9. Bedard P-A, Alcorta D, Simmons DL, Luk K-C, Erikson RL (1987) Constitutive expression of a gene encoding a polypeptide homologous to biologically active human platelet protein in Rous sarcoma virus-transformed fibroblasts. Proc Natl Acad Sci USA 84:6715-6719.
10. 10. Yoshimura T, Matsushima K, Tanaka S, Robinson EA, Appella E, Oppenheim JJ, Leonard EJ (1987) Purification of human monocyte-derived neutrophil chemotactic factor that has peptide sequence similarity to other host defense cytokines. Proc Natl Acad Sci USA 84:9233-9237.
11. 11. Richmond A, Thomas HJ (1988) Melanoma growth stimulatory activity: Isolation from human melanoma tumors and characterization of tissue distribution. J Cell Biochem 36:185-198.
12. 12. Rollins BJ, Stiles CD (1989) Serum-inducible genes. Adv Cancer Res 53:1-32.
13. 13. Derynck R, Balentien E, Han JH, Thomas HG, Wen D, Samantha AK, Zachariae CO, Griffin PR, Brachmann R, Wong WL, Matsushima K, Richmond A (1990) Recombinant expression, biochemical characterization, and biological activities of the human MGSA/gro protein. Biochemistry 29:10225-10233.
14. 14. Martins-Green M, Aotaki-Keen A, Hjelmeland L, Bissell MJ (1992) The 9E3 protein: immunolocalization in vivo and evidence for multiple forms in culture. J Cell Sci 101:701-707.
15. 15. Baggiolini M, Dewald B, Moser B (1997) Human chemokines: an update. Annual Review of Immunology 15:675-705.
16. 16. Adams DH, Loyd AR (1997) Chemokines: leukocyte recruitment and activation cytokines. Lancet 349:490-495.
17. 17. Stoeckle MY, Barker KA (1990) Two burgeoning families of platelet factor 4-related proteins: Mediators of the inflammatory response. The New Biologist 2:313-323.
18. 18. Sager R, Haskill S, Anisowicz A, Trask D, Pike MC (1991) GRO: a novel chemotactic cytokine. Adv Exp Med Biol 305:73-77.
19. 19. Sherry B, Cerami A (1991) Small cytokine superfamily. Curr Opin Immunol 3:56-60.
20. 20. Mukaida N, Matsushima K (1992) Regulation of IL-8 production and the characteristics of the receptors for IL-8. Cytokine 4:41-53.
21. 21. Oppenheim JJ (1993) Overview of chemokines. Adv Exp Med Biol 351:183-186.
22. 22. Sozzani S, Locati M, Allavena P, Van Damme J, Mantovani A (1996) Chemokines: a superfamily of chemotactic cytokines. J Clin Lab Res 26:69-82.
23. 23. Clore GM, Appella E, Yamada M, Matsushima K, Gronenborn AM (1990) Three-dimensional structure of interleukin 8 in solution. Biochemistry 29:1689-1693.
24. 24. Baldwin ET, Weber IT, St. Charles R, Xuan J-C, Appella E, Yamada M, Matsushima K, Edwards BFP, Clore GM, Gronenborn AM, Wlodawer A (1991) Crystal structure of interleukin 8: symbiosis of NMR and crystallography. Proc Natl Acad Sci USA 88:502-506.
25. 25. Fairbrother WJ, Reilly D, Colby TJ, Hesselgesser J, Horuk R (1994) The solution structure of melanoma growth stimulating activity. J Mol Biol 242:252-270.
26. 26. Fairbrother WJ, Shelton NJ (1996) Three-dimensional structures of the chemokine family. In Horuk R (ed.) Chemoattractant Ligands and Their Receptors, 55-86, New York: CRC Press.
27. 27. Clark-Lewis I, Kim K-S, Rajarathnam K, Gong J-H, Dewald B, Moser B (1995) Structure-activity of chemokines. J Leukocyte Biol 57:703-711.
28. 28. Clore GM, Gronenborn AM (1995) Three-dimensional structure of alpha and beta chemokines. In Horuk R (ed.) Chemoattractant Ligands and Their Receptors. New York: CRC Press.
29. 29. Gupta SK, Hassel T, Singh JP (1995) A potent inhibitor of endothelial cell proliferation is generated by proteolytic cleavage of the chemokine platelet factor 4. Proc Natl Acad Sci USA 92:7799-7803.
30. 30. Osterman DG, Griffin GL, Senior RM, Kaiser ET, Deuel TF (1982) The carboxy-terminal tridecapeptide of platelet factor 4 is a potent chemotactic agent for monocytes. Biochem Biophys Res Commun 107:130-135.
31. 31. Zucker MB, Katz IR, Thorbecke GJ, Milot DC, Holt J (1989) Immunoregulatory activity of peptide related to platelet factor-4. Proc Natl Acad Sci USA 86:7571-7574.
32. 32. Maione TE, Gray SG, Petro J, Hunt A, Donner AL, Bauer SI, Carson HF, Sharpe RJ (1990) Inhibition of angiogenesis by recombinant human platelet factor-4 and related peptides. Science 247:77-79.
33. 33. Martins-Green M, Stoeckle M, Wimberly S, Hampe A, Hanafusa H (1996) The 9E3/CEF4 cytokine: kinetics of secretion, processing by plasmin, and interaction with extracellular matrix. Cytokine 8:448-459.
34. 34. Martins-Green M, Bissell MJ (1990) Localization of 9E3/CEF-4 in avian tissues: Expression is absent in Rous sarcoma virus-induced tumors but is stimulated by injury. J Cell Biol 110:581-595.
35. 35. Vaingankar S, Martins-Green M (1997) Thrombin activation of the 9E3/CEF4 chemokine involves tyrosine kinases including c-src and the EGF receptor. J Biol Chem 273:5226-5234.
36. 36. Clark RAF, Henson PM (1996) (eds) The Molecular and Cellular Biology of Wound Repair. New York: Plenum Press.
37. 37. Martins-Green M, Feugate JE (1998) The 9E3/CEF4 gene product is a chemotactic and angiogenic factor that can initiate the wound healing cascade in vivo. Cytokine 10:522-535.
38. 38. Horuk R (1996) In Horuk R (ed.) Chemoattractant Ligands and Their Receptors, 337 pp. New York: CRC Press.
39. 39. Vu MT, Smith CF, Burger PC, Klintworth GK (1985) Methods in laboratory investigation. An evaluation of methods to quantitate the chick chorioallantoic membrane assay in angiogenesis. Lab Invest 4:499-508.
40. 40. Klagsbrun M, D'Amore PA (1991) Regulators of angiogenesis. Annu Rev Physiol 53:217-239.
41. 41. Cockerill GW, Gamble JR, Vadas MA (1995) Angiogenesis: models and modulators. Internatl Rev Cytol 159:113-160.
42. 42. Swerlick RA (1995) Angiogenesis. J Dermatol 22:845-852.
43. 43. Yang EY, Moses HL (1990) Transforming growth factor β1-induced changes in cell migration, proliferation, and angiogenesis in the chicken chorioallantoic membrane. J Cell Biol 111:731-741.
44. 44. Saksela O, Moscatelli D, Rifkin DB (1987) The opposing effects of fibroblast growth factor and transforming growth factor beta on the regulation of plasminogen activator activity in capillary endothelial cells. J Cell Biol 105:975-963.
45. 45. Sato Y, Rifkin DB (1988) Autocrine activities of basic fibroblast growth factor: Regulation of endothelial cell movement, plasminogen activator synthesis, and DNA synthesis. J Cell Biol 107:1199-1205.
46. 46. Rutledge BJ, Rayburn H, Rosenberg R, North RJ, Gladue RP, Corless CL, Rollins BJ (1995) High level MCP-1 expression in transgenic mice increases their susceptibility to intracellular pathogens. J Immunol 155:4838-4843.
47. 47. Strosberg AD (1995) Structure, function and regulation of the three beta-adrenergic receptors. Obesity Res 3 (Suppl. 4):501S-505S.
48. 48. Hipkin RW, Friedman J, Clark RB, Eppler CM, Schonbrunn A (1997) Agonist-induced desensitization, internalization, and phosphorylation of the sst2A somatostatin receptor. J Biol Chem 272:13869-13876.
49. 49. Bastepe M, Ashby B (1997) The long cytoplasmic carboxyl terminus of the prostaglandin E2 receptor EP4 subtype is essential for agonist-induced desensitization. Mol Pharmacol 51:343-349.
50. 50. Thompson WD, Campbell R, Evans T (1985) Fibrin degradation and angiogenesis: Quantitative analysis of the angiogenic response in the chick chorioallantoic membrane. J Pathology 145:27-37.
51. 51. Sholley MM, Ferguson GP, Seibel HR, Montour JL, Wilson JD (1984) Mechanisms of neovascularization: Vascular sprouting can occur without proliferation of endothelial cells. Lab Invest 51:624-634.
52. 52. Folkman J, Sing Y (1992) Control of angiogenesis by heparin and other sulfated polysaccharides. Adv Exp Med Biol 313:355-364.
53. 53. Wijelath ES, Carlsen B, Cole T, Chen J, Kothari S, Hammond WP (1997) Oncostatin M induces basic fibroblast growth factor expression in endothelial cells and promotes endothelial cell proliferation, migration and spindle morphology. J Cell Sci 110:871-879.
54. 54. Pedram A, Razandi M, Hu RM, Levin ER (1997) Vasoactive peptides modulate vascular endothelial cell growth factor production and endothelial cell proliferation and invasion. J Biol Chem 272:17097-17103.
55. 2-terminal residues and evidence for uncoupling of neutrophil chemotaxis, exocytosis, and receptor binding activities. J Biol Chem 266:23128-23134.
56. 56. Clark-Lewis I, Dewald B, Geiser T, Moser B, Baggiolini M (1993) Platelet factor 4 binds to interleukin-8 receptors and activates neutrophils when the N-terminus is modified with Glu-Leu-Arg. Proc Natl Acad Sci USA 90:3574-3577.
57. 57. Hébert CA, Vitangcol RV, Baker Jb (1991) Scanning mutagenesis of interleukin-8 identifies a cluster of residues required for receptor binding. J Biol Chem 266:18989-18994.
58. 58. Hébert, Lowman (1996) In Horuk R (ed.) Chemoattractant Ligands and Their Receptors, 377 pp. New York: CRC Press.
59. 59. Strieter RM, Polverini PJ, Arenberg DA, Walz A, Opdenakker G, Van Damme J, Kunkel SL (1995b) Role of C-X-C chemokines as regulators of angiogenesis in lung cancer. J Leukocyte Biol 57:752-762.
60. 60. Roby P, Page M (1994) Cell-binding and growth-stimulating activities of the C-terminal part of human MGSA/Groα. Biochem Biophys Res Commun 206:792-798.
61. 61. Roby P, Page M (1995) Cell-binding and growth-stimulating activities of the C-terminal part of human MGSA/Groα. Biochem Biophys Res Commun 206:792-798.
62. 62. Richmond A, Shattuck RL (1996) Melanoma growth stimulatory activity: physiology, biology, structure/function, and role in disease. In Horuk R (ed.) Chemoattractant Ligands and Their Receptors. 87-124, New York: CRC Press.
63. 131I labeled human growth hormone of high specific activity. Biochem J 89:114-124.
64. 64. Martins-Green M, Boudreau N, Bissell MJ (1994) Inflammation is responsible for the development of wound tumors in RSV-infected newly-hatched chicks. Cancer Res 54:4334-4341.